KEY POINTS:
Wool Equities shareholders have backed the company's strategy to invest in biotechnology, voting at Thursday's annual meeting against five board nominees wanting to focus on commercial wool growing.
Shareholders also voted down a no-confidence motion in the board, and a resolution that Wool Equities cease its reliance on its biotechnology investments in favour of a portfolio of commercially profitable wool-related, value-adding investments.
